Literature DB >> 33777298

A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report.

Jehanne Aasfara1, Amal Hajjij2, Hatim Bensouda2, Hamid Ouhabi1, Fouad Benariba2,3.   

Abstract

SARS-CoV-2 is an infection due to a novel virus belonging to the coronavirus family. Since December 2019, first human cases of COVID-19 have been identified in Wuhan (China) and rapidly has been progressed to a global pandemic declared by the world health organization (WHO) on March 11th 2020. The major complication of COVID-19, is pneumonia, but other presentations like cardiovascular and neurological complications have been reported. Herein, we report a first case of pregnant women presented with bifacial weakness and paraesthesia (BFP) associated to a vestibulocochlear neuritis as post-COVID-19 manifestation. This is a 36-year-old Moroccan female patient with a history of SARS-CoV-2 positive 6 weeks before admission. She presented to the emergency department with rapid bifacial paralysis, bilateral lower extremity paresthesia, vertigo, nausea, vomiting and right auricular pain. An acute stroke was ruled out after neurological examination and brain MRI. Clinical presentation, neurophysiological, audiometry and videonystagmography workup additionally to CSF findings were suggestive of a variant of Guillain Barré Syndrome (GBS), which is BFP associated to right vestibulocochlear neuritis. The patient was treated with Intravenous immunoglobulins (IVIG) therapy associated with intravenous steroids. The patient made a complete recovery of the right facial palsy and the sensorineural hearing loss but still have tingling in lower limbs and left facial palsy at 2 weeks´ follow-up. BFP can be induced by COVID-19 as a postinfectious immune-mediated complication. Regarding the pathophysiology of vestibular neuritis, is probably similar to other viral infection causing nerve damage. Clinicians should consider the association of vestibulocochlear neuritis and BFP as a post SARS-CoV-2 manifestation. Copyright: Jehanne Aasfara et al.

Entities:  

Keywords:  Bifacial weakness and paresthesia; Guillain Barré syndrome; SARS-CoV-2; case report; vestibulocochlear neuritis

Mesh:

Substances:

Year:  2021        PMID: 33777298      PMCID: PMC7955605          DOI: 10.11604/pamj.2021.38.30.27646

Source DB:  PubMed          Journal:  Pan Afr Med J


  8 in total

1.  COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome.

Authors:  K L Hutchins; J H Jansen; A D Comer; R V Scheer; G S Zahn; A E Capps; L M Weaver; N A Koontz
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

Review 2.  Viruses and vestibular neuritis: review of human and animal studies.

Authors:  L E Davis
Journal:  Acta Otolaryngol Suppl       Date:  1993

3.  The First Case of Vestibulocochlear Neuritis in a Patient with Acquired Immunodeficiency Syndrome in Korea.

Authors:  Hyun Joo Park; Chin Saeng Cho; Nak Min Kim; Su A Yun; Hee Jung Yoon
Journal:  Infect Chemother       Date:  2016-06-30

Review 4.  Neurologic complications of COVID-19.

Authors:  Rachel Bridwell; Brit Long; Michael Gottlieb
Journal:  Am J Emerg Med       Date:  2020-05-16       Impact factor: 2.469

5.  Guillain-Barré syndrome in a patient previously diagnosed with COVID-19.

Authors:  Alexandria C Defabio; Thomas R Scott; Robert T Stenberg; Erin L Simon
Journal:  Am J Emerg Med       Date:  2020-08-04       Impact factor: 2.469

Review 6.  Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  Muscle Nerve       Date:  2015-09-12       Impact factor: 3.217

7.  Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.

Authors:  Samir Abu-Rumeileh; Ahmed Abdelhak; Matteo Foschi; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2020-08-25       Impact factor: 4.849

  8 in total
  6 in total

1.  Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational Study.

Authors:  François Lersy; Caroline Bund; Mathieu Anheim; Mary Mondino; Vincent Noblet; Shirley Lazzara; Clelie Phillipps; Olivier Collange; Walid Oulehri; Paul-Michel Mertes; Julie Helms; Hamid Merdji; Maleka Schenck; Francis Schneider; Julien Pottecher; Céline Giraudeau; Agathe Chammas; François-Daniel Ardellier; Seyyid Baloglu; Khalid Ambarki; Izzie Jacques Namer; Stéphane Kremer
Journal:  Viruses       Date:  2022-05-01       Impact factor: 5.818

Review 2.  Post COVID-19 neurological complications; a meta-analysis.

Authors:  Jaafar Omer Ahmed; Shwan Abdubakr Ahmad; Marwan Nasih Hassan; Fahmi H Kakamad; Rawezh Q Salih; Berwn A Abdulla; Fattah Hama Rahim Fattah; Shvan H Mohammed; Razhan K Ali; Abdulwahid M Salih
Journal:  Ann Med Surg (Lond)       Date:  2022-03-03

Review 3.  Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism.

Authors:  Anushri Umesh; Kumar Pranay; Ramesh Chandra Pandey; Mukesh Kumar Gupta
Journal:  Infection       Date:  2022-04-30       Impact factor: 7.455

Review 4.  Pregnancy and neurologic complications of COVID-19: A scoping review.

Authors:  João Eudes Magalhães; Pedro Augusto Sampaio-Rocha-Filho
Journal:  Acta Neurol Scand       Date:  2022-04-07       Impact factor: 3.915

Review 5.  Sensorineural Hearing Loss Post-COVID-19 Infection: An Update.

Authors:  Virginia Fancello; Giuseppe Fancello; Stavros Hatzopoulos; Chiara Bianchini; Francesco Stomeo; Stefano Pelucchi; Andrea Ciorba
Journal:  Audiol Res       Date:  2022-06-01

6.  SARS-CoV-2 (COVID-19) and audio-vestibular disorders.

Authors:  Virginia Fancello; Stavros Hatzopoulos; Virginia Corazzi; Chiara Bianchini; Magdalena B Skarżyńska; Stefano Pelucchi; Piotr Henryk Skarżyński; Andrea Ciorba
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.